Live Oak Hma, LLC
Live Oak Hma, LLC was paid $6.55M by Medicaid between Jan 2018 and Apr 2020, across 80 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 8.5% of everything it billed.
LIVE OAK, FL 32064
Next to other Critical Access Hospital providers in Florida
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,482 | $1.76M | |
| 2019 | 43,453 | $3.28M | |
| 2020 | 12,617 | $1.51M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 8.5% | 4,517 | 3,300 | $555K |
| 80053 | Comprehensive metabolic panel | 6.6% | 4,270 | 3,194 | $433K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.6% | 4,339 | 3,283 | $367K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.5% | 6,527 | 5,180 | $359K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.9% | 4,639 | 3,527 | $319K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.7% | 1,889 | 1,481 | $308K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.9% | 1,843 | 1,439 | $253K |
| 84484 | 3.8% | 1,384 | 1,020 | $249K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 3.7% | 1,749 | 1,303 | $240K |
| 71045 | Radiologic examination, chest; single view | 3.2% | 1,651 | 1,326 | $210K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.2% | 2,623 | 2,038 | $209K |
| 87040 | 3.1% | 967 | 532 | $205K |
68 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | 3.1% | 1,372 | $202K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3.0% | 1,696 | $196K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 2,022 | $184K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 893 | $174K |
| 81003 | 2.2% | 1,991 | $141K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2.1% | 899 | $135K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2.0% | 651 | $131K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.8% | 847 | $121K |
| 83605 | 1.6% | 588 | $104K | |
| 82803 | 1.5% | 568 | $99K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.4% | 1,043 | $90K |
| 81001 | 1.3% | 1,479 | $86K | |
| 36600 | 1.3% | 315 | $86K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1.2% | 1,273 | $81K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.2% | 826 | $81K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.2% | 450 | $78K |
| 83880 | 1.1% | 392 | $70K | |
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 1,068 | $67K |
| 83690 | <1% | 796 | $62K | |
| 81025 | <1% | 1,453 | $51K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 378 | $45K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 527 | $39K |
| 87430 | <1% | 2,038 | $37K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,101 | $33K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,371 | $32K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 484 | $32K |
| 80306 | <1% | 543 | $30K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 498 | $28K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 190 | $25K |
| 82550 | <1% | 76 | $23K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 264 | $22K |
| 85378 | <1% | 161 | $22K | |
| 94760 | <1% | 271 | $21K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 177 | $15K |
| 73630 | <1% | 190 | $14K | |
| 82962 | <1% | 163 | $13K | |
| 73130 | <1% | 211 | $13K | |
| 83735 | <1% | 80 | $12K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 171 | $11K |
| 74018 | <1% | 211 | $10K | |
| 85610 | <1% | 44 | $10K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 204 | $10K |
| 85730 | <1% | 43 | $9K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 19 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 46 | $8K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 300 | $8K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 97 | $8K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 367 | $7K |
| 87186 | <1% | 173 | $7K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 37 | $6K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 38 | $6K |
| 73610 | <1% | 109 | $6K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 86 | $5K |
| 87088 | <1% | 93 | $4K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 35 | $4K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 43 | $4K |
| 72100 | <1% | 61 | $2K | |
| 96376 | <1% | 31 | $2K | |
| 73030 | <1% | 32 | $1K | |
| 73564 | <1% | 18 | $1K | |
| 90714 | <1% | 17 | $716.54 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 53 | $563.42 |
| 73110 | <1% | 16 | $541.03 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 15 | $450.34 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 60 | $153.19 |
| 87807 | <1% | 318 | $109.52 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 56 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.